Skip to content

13F-HR filed by a16z Capital Management, L.L.C.

a16z Capital Management, L.L.C. filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-12, with 12 holding rows worth $745,255,646.

Accession
0001104659-25-012178
Filed
2025-02-12
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2024

A holdings report, 12 entries on the cover page, a total value of $745,255,646 stated on the cover page (in dollars after the unit check, H1), rows summing to $745,255,646 with VALUE read as dollars as filed, 13F file number 028-23922. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
DOORDASH INC CL A25809K105Stock1,597,010$267,898,428dollars as filed
SAMSARA INC COM CL A79589L106Stock3,995,652$174,570,036dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock2,748,523$120,220,396dollars as filed
BLOCK INC CL A852234103Stock1,016,697$86,409,078dollars as filed
NAUTILUS BIOTECHNOLOGY INC63909J108COM17,653,917$29,658,581dollars as filed
BIOAGE LABS INC COM09077V100Stock3,233,170$18,720,054dollars as filed
ACCOLADE INC00437E102COM5,398,708$18,463,581dollars as filed
CAMP4 THERAPEUTICS CORP13463J101COM2,125,339$11,094,270dollars as filed
OPENDOOR TECHNOLOGIES INC683712103COM6,200,821$9,921,314dollars as filed
ERASCA INC COM29479A108Stock2,862,500$7,184,875dollars as filed
GINKGO BIOWORKS HOLDINGS INC37611X209COMMON STOCK108,568$1,066,138dollars as filed
NULL23257B206NULL57,584$48,895dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-25-012178this filing2025-02-12acceptance time not in the bulk data set